CytoDyn Inc. submits the first of three main sections of its HIV Biologics License Application to FDA under rolling review
Fresh from the biotech pipeline: fewer approvals, but biologics gain share | Nature Biotechnology
FDA Programs to Expedite Drug and Biologic Product Development - The ASCO Post
CDER 21st Century Review Desk Reference Guide
CorMedix eyes US FDA priority review for bloodstream infection drug Defencath | S&P Global Market Intelligence
Eli Lilly gets FDA's speedy review for obesity drug | Reuters
TRIbune Winter 2015 - The FDA's Expedited Review Process: The Need for Speed
Accelerate Your Review with Rolling NDA & BLA Submissions
FDA's Expedited Review Process: The Need for Speed
Lumicell's LUM Imaging System for Breast Cancer Wins FDA Fast Track
CytoDyn submits the first section of HIV BLA to FDA under rolling review | Seeking Alpha
Center for Drug Evaluation, Taiwan
Real-Time Oncology Review | FDA
A User Guide To FDA's
FDA's Expedited Review Process: The Need for Speed
Expediting Drug Development — The FDA's New “Breakthrough Therapy” Designation | NEJM
Analysis of the Real-Time Oncology Review (RTOR) Pilot Program for Approvals of New Molecular Entities | SpringerLink
패스트트랙과 혁신치료제 지정 : 네이버 블로그
Accelerated Change: Understanding the FDA's Expedited Pathways
Rolling Reviews During COVID-19: The European Union Experience in a Global Context - ScienceDirect
Development and Regulation of Medical Countermeasures for COVID-19 (Vaccines, Diagnostics, and Treatments): Frequently Asked Questions - EveryCRSReport.com
